Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Pharmacists need MHFA training
Just as CPR training can help save a life, mental health first aid (MHFA) is vital education for all pharmacy staff.
Managing chronic wounds
For Australians living with chronic wounds, pharmacy wound clinics can provide an accessible journey to healing.
Meet the 2023 NSW PSA Excellence Awards winners
They paved the way for expanded scope of practice for pharmacists, vital programs that advanced the profession, important research and opioid harm minimisation.
Four high...
Quitting smoking is more important than ever. Here’s how pharmacists can...
A new study found people who smoke are 1.4 times more likely to have severe symptoms of COVID-19 and about 2.4 times more likely to be admitted to an intensive care unit, need mechanical ventilation or die compared to non-smokers.
Top tips for reaching undervaccinated groups
These patient cohorts are missing out on vaccinations for diseases that pose serious health risks. Here’s how pharmacists can help.
The neurosciences specialist
Finding his niche in neuroscience, the Alfred Hospital’s Julian Ellis MPS, is championing brain-related disease management in all facets of pharmacy.
How did you wind...
